In the studies of Cablé et al. and Suto et al., it was found that EHHADH had a significantly low expression in colon cancer and hepatocellular carcinoma and could be used as a potential prognostic marker [55, 56]. Here, EHHADH is linked to hepatocellular carcinoma.